A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
Recruiting now · Not applicable
Conditions studied: Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation
In brief
The study will evaluate the safety and 12-month effectiveness of the Pulmonary Vein Isolation plus Box Isolation of Fibrotic Areas (BIFA) ablation strategy with the Globe Pulsed Field System (Globe PF System) for the treatment of atrial fibrillation.
Key facts
- Study ID
- NCT06973031
- Run by
- Kardium Inc.
- People needed
- 115
- Starts
- 2025-06-10
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2025-06-16
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Westpfalz-Klinikum GmbH Kaiserslautern — Kaiserslautern, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.